US hits sad milestone: 500,000 COVID-19 deaths

COVID-19 has caused or hastened the deaths of more than half a million U.S. residents, according to updated data from Johns Hopkins.

Globally, the novel coronavirus has infected more than 111 million individuals and killed 2.5 million. The U.S. has recorded more than 28 million confirmed cases. While there were about 100,000 U.S. deaths in just the past five weeks alone and the virus became the leading cause of death in the nation, there is some good news on the horizon. More than 65 million vaccines have already been administered, according to the CDC, suggesting the end of the pandemic may be in sight.

“As a nation, we can’t accept such a cruel fate” as mass suffering and death, President Biden said Feb. 22 as the U.S. passed the milestone. “While we have been fighting this pandemic for so long, we have to resist becoming numb to the sorrow.”

Unfortunately, the U.S. ranks No. 1 in the world for COVID-19 deaths, and the country has been gripped by political influences when it comes to advice on reducing exposure and spread of the virus. 

Recently, the CDC recommended that individuals add layers to increase their protection from the virus, such as wearing two face masks or coverings.

As a result of the tragic death toll, Biden lowered all flags on federal property to half mast for the week of Feb. 22.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.